Patent · US Active

NMDA antagonist prodrugs

US9822075B2 · kind B2 · utility

2Cited by

7References

12Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Gunnar Nordvall · Gately Drive, SE
Katharina Högdin · Knivsta, SE
Per Jonas Malmborg · Linköping, SE
Annika Kers · Malung, SE
Dirk Reinhold Weigelt · Åkersberga, SE
Peter Bernstein · Wallingford, US
Michael Quirk · Acton, US
Michael Balestra · Wilmington, US

Key dates

Filing date	Oct 30, 2014
Grant date	Nov 21, 2017
Priority date	—
Expiry date	Nov 12, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Prodrugs of an NMDA antagonist, (S)-1-phenyl-2-(pyridin-2-yl)ethanamine, useful for the treatment of depression (particularly major depressive disorder) or pain; compositions comprising them, and methods of making them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.